Bryxta 300mg Injection
Byraxta 300 mg Injection contains bevacizumab, a recombinant humanized monoclonal antibody that binds selectively to vascular endothelial growth factor A (VEGF-A). By neutralizing VEGF-A, Byraxta …
Bryxta 300mg Injection - 300mg
Complete information about this pharmaceutical product including specifications, manufacturer details, and availability.
Bryxta 300mg Injection
By Zydus Lifesciences Ltd
All prices are inclusive of taxes
Dosage
300mg
Pack Size
1 Vial of 12ml
Active Ingredient/Salt
Bevacizumab
Product Description
Byraxta 300 mg Injection contains bevacizumab, a recombinant humanized monoclonal antibody that binds selectively to vascular endothelial growth factor A (VEGF-A). By neutralizing VEGF-A, Byraxta effectively inhibits angiogenesis, the formation of new blood vessels that tumors depend on for growth and metastasis. This mechanism essentially “starves” the tumor of nutrients and oxygen, helping slow disease progression. Byraxta is commonly used alongside chemotherapy to treat multiple advanced solid tumors, including metastatic colorectal cancer, non-small cell lung cancer, renal cell carcinoma, ovarian and cervical cancers, and recurrent glioblastoma. It is administered under controlled intravenous infusion by qualified oncology healthcare teams to ensure patient safety and optimal outcomes.
Key Benefits
* Directly targets VEGF to reduce blood supply to tumors, slowing cancer growth
* Works synergistically with chemotherapy to improve treatment effectiveness
* Clinically shown to increase progression-free survival across several types of advanced cancers
* Approved for use in managing cancers of the colon, lung, kidney, ovary, cervix, and brain
* Administered by trained medical professionals under strict hospital protocols to minimize risk
Price
₹ 8,900/Vial
₹ 28,995/Vial
Save 69% off MRP
Dosage
300mg
Pack Size
1 Vial of 12ml
Manufacturer
Zydus Lifesciences Ltd
Active Ingredient
Bevacizumab
Why Choose Bryxta 300mg Injection?
We ensure the highest quality standards and authentic pharmaceutical products for your healthcare needs.
Authentic Product
100% authentic Bryxta 300mg Injection sourced directly from Zydus Lifesciences Ltd.
Quality Control
Rigorous quality checks and WHO-GMP certified storage facilities ensure product integrity.
Fast Delivery
Quick and secure delivery with proper cold chain management for temperature-sensitive products.
Expert Support
Our pharmaceutical experts provide technical support and guidance for all your medication needs.
Alternative Medicines with Same Salt
Discover other products containing the same active ingredient (Bevacizumab) that may serve as alternatives.
Bevatas 100mg Injection - 100mg
Category: Oncology & Cancer Care
Bevatas 400mg Injection - 400mg
Category: Oncology & Cancer Care
Bryxta 100mg Injection - 100mg
Category: Oncology & Cancer Care
Showing 3 of available alternatives
Important: These are alternative medicines with the same active ingredient. Please consult with your healthcare provider before making any substitutions.
Related Oncology & Cancer Care Products
Explore other quality products from the same category.
Alburel 20% Injection 100ml
Alburel 20% Solution is a high-concentration human albumin preparation used for…
Bevatas 100mg Injection
Bevatas 100mg Injection contains bevacizumab, a recombinant humanized monoclona…
Bevatas 400mg Injection
Bevatas 400mg Injection contains bevacizumab, a recombinant monoclonal antibody…
More from Zydus Lifesciences Ltd
Explore other quality products from the same trusted manufacturer.
Bryxta 100mg Injection
Byraxta 100 mg Injection contains bevacizumab, a humanized monoclonal antibody …
Bryxta 400mg Injection
Byraxta 400 mg Injection contains bevacizumab, a recombinant humanized monoclon…
Obnyx 40mg Tablet
Obynx 40mg Capsule contains enzalutamide, a non-steroidal androgen receptor inh…
Ready to Order Bryxta 300mg Injection?
Get competitive pricing, bulk discounts, and expert support for Bryxta 300mg Injection. Contact our pharmaceutical experts today for personalized service and authentic products.